Pricing Log in Create free account

BridgeBio Oncology Therapeutics, Inc (BBOT) vs Bicycle Therapeutics PLC Sponsored ADR (BCYC)

BridgeBio Oncology Therapeutics, Inc and Bicycle Therapeutics PLC Sponsored ADR are both Biotechnology companies. Bicycle Therapeutics PLC Sponsored ADR is the larger, with a market value of $182.5M against $163.6M — 1.1× the size. BridgeBio Oncology Therapeutics, Inc has the higher net margin (0.00% vs −169.8%) and the higher return on invested capital (−127.7% vs −279.8%). Across the 13 metrics below, Bicycle Therapeutics PLC Sponsored ADR leads on 7 and BridgeBio Oncology Therapeutics, Inc on 6.

Valuation

Metric BBOT BCYC Biotechnology median
P/E n/m n/m 10.60
P/S n/m 3.02 9.40
P/B 0.51 0.50 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.31 1.28 0.66
EV/Sales n/m (2.35) 9.02
Earnings yield (135.29%) (56.22%) (32.88%)
Free cash flow yield (92.81%) (70.08%) (23.13%)

Profitability

Metric BBOT BCYC Biotechnology median
Gross margin — 100.00% 68.51%
Operating margin 0.00% (189.43%) 0.00%
Net margin 0.00% (169.75%) 0.00%
Free cash flow margin 0.00% (211.95%) 0.00%
Return on equity (252.10%) (25.24%) (51.96%)
Return on assets (96.69%) (21.30%) (46.06%)
Return on invested capital (127.66%) (279.76%) 0.00%

Growth

Metric BBOT BCYC Biotechnology median
Revenue growth (TTM) — 194.75% 6.76%
EPS growth (last fiscal year) 99.93% (8.97%) 29.88%
Revenue growth, 5-year CAGR — 47.52% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric BBOT BCYC Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.69 12.09 4.97
Net debt to EBITDA 2.93 2.61 1.01

Dividend

Metric BBOT BCYC Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BBOT BCYC Biotechnology median
Market cap 163.56m 182.52m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack